title: Frequency of creatine kinase elevation during treatment with fluvastatin.
authors.affiliation: Novartis Pharma LTD, Basel, Switzerland.
authors.forename: Renee
authors.initials: R
authors.lastname: Benghozi
authors.forename: Michele
authors.initials: M
authors.lastname: Bortolini
authors.forename: Yan
authors.initials: Y
authors.lastname: Jia
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Isaacsohn
authors.forename: August J
authors.initials: AJ
authors.lastname: Troendle
authors.forename: Leonard
authors.initials: L
authors.lastname: Gonasun
mesh_terms: D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003402:Creatine Kinase / Q000097:blood / Q000187:drug effects*; D003692:Delayed-Action Preparations; D005229:Fatty Acids, Monounsaturated / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D000077340:Fluvastatin; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D007211:Indoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D000924:Anticholesteremic Agents; D003692:Delayed-Action Preparations; D005229:Fatty Acids, Monounsaturated; D007211:Indoles; D000077340:Fluvastatin; D003402:Creatine Kinase